Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Musculoskeletal tissue models: Investigation of structural signaling pathways
Inhibits macrophage activity at the maternal-fetal interface
In very rare cases, serious hypersensitivity reactions can occur after B12 injections, requiring immediate medical attention
Expected timeline (Protocol A): For reconstitution and site rotation, see the GHK-Cu injection dosage guide
Loading phase protocol (acute injury or initial treatment): Dose: 500 mcg to 1 mg per injection Frequency: Once daily Duration: 7 to 10 days Injection site: Subcutaneous, ideally near the area of concern Timing: Morning or evening, consistency matters more than specific time Maintenance phase protocol: Dose: 500 mcg to 1 mg per injection Frequency: 2 to 3 times per week Duration: 4 to 8 weeks total protocol length Cycle recommendation: 2 months on, 2 months off Unlike traditional BPC-157 acetate, which is often administered twice daily due to its shorter half-life, the enhanced stability of the arginate form typically allows for once-daily dosing during the loading phase
Gel packs and insulated containers maintain sub-zero temperatures for 2448 hours under optimal conditions, but delays, ambient temperatures above 30C, or improper packing can result in partial thawing
